Healix

Clinical Success in Outpatient Treatment of Complicated Urinary Tract Infections (UTI) with Ertapenem

Authors:
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX
Philip S. Brachman, MD – Atlanta Infectious Disease Group, Atlanta, GA
Fernando S. Alvarado, MD – Infectious Disease Consultants, Altamonte Springs, FL
Jennifer L. Christensen – Healix Infusion Therapy, Inc., Sugar Land, TX

View Poster View Abstract

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound